Jonathan Miller, MD, discusses earlier HPV vaccination, individualized conversations with hesitant families, and strategies to improve vaccine uptake.
|Poll|September 21, 2020
How comfortable are providers with telehealth?
Do providers feel like they have successfully adapted to providing telehealth services, as compared to the beginning of the pandemic?
Advertisement
Do you feel you have successfully adapted to providing telehealth services, as compared to the beginning of the pandemic (March 2020)?
Advertisement
Related to this article
Jonathan Miller, MD, discusses factors behind lagging HPV vaccination rates and how pediatricians can address common parent concerns.
The latest IDSA histoplasmosis update adds a consensus statement on severe disease and outlines when children with pulmonary infection warrant itraconazole therapy.
This FAQ breaks down the AAP's newest COVID-19, RSV, and influenza recommendations for clinicians who want a quick refresher on what changed for the 2026-2027 season.
XOCOVA gives pediatricians a new oral option to help prevent COVID-19 after exposure in adolescents aged 12 years and older.
Five rapid developments — new mRNA flu vaccine, CDC director, ACIP/NVAC charters, a vaccine order, and an HHS RFI — roil the 2026 schedule.
Court fight over CDC 2026 childhood vaccine schedule shifts shots to shared decision-making; experts warn lower uptake for Hep A, B, flu, COVID.
New evidence supports influenza, COVID-19, and RSV immunizations for reducing severe respiratory illness and hospitalization.
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
FDA approves baricitinib for adolescents with severe alopecia areata
2
Starting HPV vaccination earlier gives pediatricians more opportunities to protect children
3
FDA approves zilurgisertib for fibrodysplasia ossificans progressiva in patients aged 12 years and older
4
FDA approves obinutuzumab to reduce relapse risk in childhood-onset idiopathic nephrotic syndrome
5